Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Can a diet pill treat cancer? There is fresh evidence that indicates type 2 diabetes and obesity medications GLP-1 receptor ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Obesity-related cancer, a generalized term to classify specific cancer types that develop more frequently in obese patients, ...